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There is substantial controversy about the addictive potential of modafinil, a wake-
promoting drug used to treat narcolepsy, proposed as pharmacotherapy for cocaine
abuse, and used indiscriminately by healthy individuals due to its positive effects on
arousal and cognition. The rapid-onset type of behavioral sensitization (i.e., a type of
sensitization that develops within a few hours from the drug priming administration)
has been emerged as a valuable tool to study binge-like patterns of drug abuse and
the neuroplastic changes that occur quickly after drug administration that ultimately
lead to drug abuse. Our aim was to investigate the possible development of
rapid-onset behavioral sensitization to modafinil and bidirectional rapid-onset cross-
sensitization with cocaine in male Swiss mice. A priming injection of a high dose
of modafinil (64 mg/kg) induced rapid-onset behavioral sensitization to challenge
injections of modafinil at the doses of 16, 32, and 64 mg/kg, administered 4 h later.
Furthermore, rapid-onset cross-sensitization was developed between modafinil and
cocaine (64 mg/kg modafinil and 20 mg/kg cocaine), in a bidirectional way. These
results were not due to residual levels of modafinil as the behavioral effects of the
priming injection of modafinil were no longer present and modafinil plasma concentration
was reduced at 4 h post-administration. Taken together, the present findings provide
preclinical evidence that modafinil can be reinforcing per se and can enhance the
reinforcing effects of stimulants like cocaine within hours after administration.
Keywords: cocaine, drug abuse, mice, modafinil, open field, rapid-onset behavioral sensitization
INTRODUCTION
Most common drugs of abuse stimulate the release of dopamine in the mesoaccumbens
dopaminergic system, which modulates both their reinforcing and psychomotor arousal effects
(Wise and Bozarth, 1987; Alcaro et al., 2007). Within this context, it has been shown that the
repeated administration of drugs of abuse promotes a progressive and long-lasting increase in
Frontiers in Pharmacology | www.frontiersin.org 1 November 2016 | Volume 7 | Article 420
fphar-07-00420 November 3, 2016 Time: 17:28 # 2
Wuo-Silva et al. Modafinil and Cocaine Abuse
the activity of the mesoaccumbens dopaminergic system, leading
to a corresponding increase in their locomotor stimulatory effect
in rodents (Vezina, 2004; Costa et al., 2007; O’Tuathaigh et al.,
2010). This phenomenon, called behavioral sensitization, has
been used to study the neurochemical mechanisms involved in
the dopaminergic mesoaccumbens plasticity that are thought to
play a major role in the reinforcing effects, incentive salience,
and craving induced by drugs with abuse potential in humans
(Robinson and Becker, 1986; Robinson and Berridge, 1993, 2008;
Vezina et al., 2007). Notably, behavioral sensitization can be
induced by short-term protocols. A challenge injection of cocaine
(Valjent et al., 2010; Marinho et al., 2014), d-amphetamine
(Frussa-Filho et al., 2004; Kameda et al., 2011), morphine
(Vanderschuren et al., 2001; Marinho et al., 2015), or ethanol
(Fukushiro et al., 2010) administered days, weeks or even months
after a single drug injection can elicit behavioral sensitization.
This single injection-induced locomotor sensitization protocol
provides a useful model for investigating the long-lasting effects
of drugs of abuse (Valjent et al., 2010).
Pioneering studies of Kuczenski and Segal (1999a,b) have also
demonstrated that sensitization may develop in a very rapid
manner. These authors showed that a few hours (3–5 h) after a
priming injection of 4 mg/kg d-amphetamine, the administration
of low, non-stereotypy-inducing doses of d-amphetamine (0.5–
1.5 mg/kg) was able to elicit sensitization of stereotyped behaviors
in rats. Later, evidence from our research group also showed
the development of this rapid-onset sensitization phenomenon
for the locomotor stimulant effect of d-amphetamine in mice
(Alvarez et al., 2006; Chinen et al., 2006). Such finding is
especially important within the context of “binge” patterns of
stimulant abuse in humans, and suggests that neuroplastic events
that mediate such abuse may occur in a rapid-onset manner.
An interesting feature of the behavioral sensitization
phenomenon is the occurrence of cross-sensitization between
different drugs of abuse such as d-amphetamine and cocaine
(Suto et al., 2002), morphine and cocaine (McDaid et al.,
2005), cocaine and ethanol (Manley and Little, 1997),
and cocaine and nicotine (Collins and Izenwasser, 2004),
suggesting common neurobiological mechanisms between these
drugs.
Modafinil (diphenyl-methyl sulphonyl-2-acetamide) is a
psychostimulant-like drug that acts as a wake-promoting
substance and has been approved for the treatment of
excessive daytime sleepiness in narcolepsy, obstructive sleep
apnea and shift workers sleep disorder (Minzenberg and
Carter, 2008). Modafinil also shows potential benefits for the
treatment of psychiatric and neurologic disorders, including
attention-deficit/hyperactivity disorder, cognitive deficits related
to schizophrenia and Alzheirmer’s disease, sleepiness and
fatigue related to Parkinson’s disease and amyotrophic lateral
sclerosis (Ballon and Feifel, 2006; Minzenberg and Carter,
2008). Moreover, modafinil has been suggested as a reasonable
medication for cocaine-addicted individuals (Dackis et al.,
2003, 2005), with some studies showing that modafinil can
attenuate the response to environmental cues related to cocaine
use (Goudriaan et al., 2013), and reduce craving for cocaine
(Hart et al., 2008). Although modafinil has emerged as a
potential therapy for cocaine abuse, the safety of modafinil,
with respect to its potential for abuse, has been questioned by
other studies, mostly performed in animal models. For example,
Gold and Balster (1996) showed the reinforcing and cocaine-
like discriminative effects of modafinil in monkeys using the
self-administration discrimination model.
It has been demonstrated that, similar to cocaine in humans,
modafinil increases dopamine release in the nucleus accumbens
by blocking the dopamine transporter (DAT) (Volkow et al.,
2009; Funayama et al., 2014) and can produce withdrawal
symptoms once its use is discontinued (Krishnan and Chary,
2015). In a study using animal models, Bernardi et al. (2009) have
demonstrated that modafinil at high doses reinstated cocaine-
induced conditioned place preference following extinction in
rats. More recently, a study from our group demonstrated
that modafinil exerts reinforcing effects, as it alone produces
conditioned place preference and induces robust behavioral
sensitization after single- and repeated-injection treatments in
mice (Wuo-Silva et al., 2011). Although, sensitization induced by
modafinil has been reported following repeated drug treatment
or by acute administration of 64 mg/kg modafinil (Wuo-Silva
et al., 2011), there is no evidence that modafinil can induce
sensitization within hours of a single administration, in a protocol
that could be compared to the binge pattern of drug abuse
seen in humans. In addition, bidirectional cross-sensitization
between modafinil and cocaine was also demonstrated in our
previous study (Wuo-Silva et al., 2011). Even though there
are several studies demonstrating the phenomenon of cross-
sensitization between drugs, including modafinil and cocaine,
using the classical sensitization model, there is none confirming
that this phenomenon also occurs in the rapid-onset type of
behavioral sensitization.
The present study aimed to investigate the possible develop-
ment of rapid-onset behavioral sensitization to the locomotor-
stimulating effect of modafinil and, subsequently, whether there
would be a bidirectional rapid-onset cross-sensitization between
modafinil and cocaine in mice.
MATERIALS AND METHODS
Subjects
Male 3-month-old Swiss EPM-M2 mice (40–45 g) from our
own colony were used. Animals were housed in polypropylene
cages (33 cm × 44 cm × 17 cm) under conditions of controlled
temperature (22–23◦C) and lighting (12/12 h light/dark, lights on
at 06:45 h). Food and water were available ad libitum throughout
the experiments. Each cage contained animals from the same
experimental group.
The experimental protocols were approved by the Committee
for the Animal Care and Ethics of UNIFESP/SP [Universidade
Federal de São Paulo (UNIFESP) #8030060514]. All animals
were housed in a pathogen-free facility and were maintained in
accordance with the National Institute of Health Guide for the
Care and Use of Laboratory Animals (NIH Publications N◦ 8023),
revised in 2011. All measures were taken to minimize the pain
and discomfort of the animals.
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Drugs
Modafinil (16, 32, 64, and 80 mg/kg, CEPHALON R©, Maisons-
Alfort, France) was dissolved in 0.5% gum arabic and 0.9%
NaCl (saline) solution. Cocaine-HCl (5, 10, and 20 mg/kg,
Sigma-Aldrich, São Paulo, Brazil) was freshly diluted in 0.9%
NaCl (saline) solution. Modafinil vehicle and saline were
used as control solutions. The solutions were administered
intraperitoneally (i.p.) at a volume of 10 ml/kg body weight.
Behavioral Test: Open Field Test
Locomotor activity was measured in the open field, as previously
described by Chinen et al. (2006). The open-field apparatus
consisted of a circular wooden box (40 cm in diameter and
50 cm high) with an open top and a floor divided into 19
squares. Using hand-operated counters and stopwatches, the
locomotion frequency (i.e., total number of entrances into any
floor unit) was measured by an observer (who was blind to the
treatment allocation) during a 10-min session. This interval has
been proven effective in detecting modafinil and cocaine-induced
behavioral sensitization induced by repeated treatment or a single
injection in mice (Wuo-Silva et al., 2011; Marinho et al., 2015).
Plasma Modafinil Concentrations
Blood samples were centrifuged at 3500 rpm for 10 min
and plasma was extracted and immediately frozen at −80◦C.
Later, samples were thawed and plasma concentrations of
modafinil were determined using liquid chromatography-
tandem mass spectrometry (LC-MS/MS) conducted on a high
performance liquid chromatography equipment Prominence
system (Shimadzu, Kyoto, Japan). The analysis was conducted at
the Forensic Toxicology Laboratory, Institute of Legal Medicine
(Sao Paulo, Brazil).
Experimental Procedures
Experiment 1. Rapid-Onset Behavioral Sensitization
to the Locomotor Stimulating Effects of Modafinil
Eighty-four mice were habituated to the open field (10-min
sessions) and to the injection procedure for three consecutive
days, and their locomotor activity was measured on day 3. After
the habituation phase, animals were allocated into seven groups
of comparable basal locomotor activity (n = 12): Veh-Veh,
Veh-Mod16, Mod64-Mod16, Veh-Mod32, Mod64-Mod32, Veh-
Mod64, and Mod64-Mod64. On the 4th day, animals received
an i.p. priming injection of vehicle solution (Veh-) or 64 mg/kg
modafinil (Mod64-). Immediately after the injections, animals
returned to their home cages. Four hours after their respective
priming injections, animals received an i.p. challenge injection
of vehicle (-Veh) or 16 mg/kg (-Mod16), 32 mg/kg (-Mod32),
or 64 mg/kg (-Mod 64) modafinil. After 30 min, animals were
placed individually in the open field and their locomotor activity
was measured for 10 min.
The dose of modafinil for the priming injections was chosen
based on a previous study from our laboratory demonstrating
the development of robust behavioral sensitization induced by
repeated administration of this dose of modafinil in mice (Wuo-
Silva et al., 2011). The time interval between the priming injection
and the challenge injection was based on previous studies by
Kuczenski and Segal (1999a,b) and from our laboratory (Alvarez
et al., 2006; Chinen et al., 2006) demonstrating the development
of rapid-onset behavioral sensitization to d-amphetamine in rats
and mice.
Experiments 2–4 were conducted in order to demonstrate that
the changes on animals’ behavior observed in Experiment 1 were
not due to residual levels of the priming injection of modafinil at
the moment of the challenge session.
Experiment 2. Time-Response Curve of the
Locomotor Stimulating Effect Induced by 64 mg/kg
Modafinil Acute Administration in Mice
Twenty mice were habituated to the open field (10-min sessions)
and to the injection procedure for three consecutive days, and
their locomotor activity was measured on day 3. After the
habituation phase, animals were allocated into two groups of
comparable basal locomotor activity (n = 10): Veh and Mod64.
On the 4th day, animals received either an i.p. injection of vehicle
solution (Veh) or 64 mg/kg modafinil (Mod64). Thirty min later,
locomotor activity was measured for 10 min, every 30 min, for a
total period of 240 min.
Experiment 3. Plasma Concentrations of Modafinil
30 min and 4 h after Acute Administration of
64 mg/kg Modafinil
Eight mice were allocated into two groups (n = 4): Mod30min
and Mod4h. Animals from both groups received an i.p. injection
of 64 mg/kg modafinil at the same time. One group of
mice was euthanized 30 min after administration of modafinil
(Mod30min group), and the other group 4 h later (Mod4h
group). Animals were euthanized by decapitation and blood
was collected in microtubes for subsequent quantification of
modafinil concentrations in plasma.
Experiment 4. Effects of a Residual Dose of Modafinil
on the Locomotor Stimulating Effect of 64 mg/kg
Modafinil
To verify whether the residual levels of modafinil found in the
plasma of animals 4 h after drug administration would affect
locomotor activity of mice, we performed Experiment 4. For
this purpose, we compared the effects of 64 mg/kg modafinil
(highest dose of modafinil used during the challenge session
of Experiment 1) with the effects of 80 mg/kg modafinil on
locomotor activity of separate groups of animals. This higher dose
of modafinil was calculated by combining the 64 mg/kg dose of
the challenge session with the residual levels of modafinil found
in the plasma of animals (16 mg/kg). To find out the residual dose
in mg/kg to be administered in combination with the 64 mg/kg
dose of modafinil, we converted mg/kg to the same unit of the
plasma concentrations (mg/ml) and considered the first plasma
measurement at 30 min (66.5 mg/ml) equivalent to the dose that
was administered to mice (64 mg/kg= 6.4 mg/ml).
Twenty-nine mice were habituated to the open field (10-min
sessions) and to the injection procedure for three consecutive
days, and their locomotor activity was measured on day 3. After
the habituation phase, animals were allocated into three groups
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FIGURE 1 | Locomotor activity during the 3rd day of habituation and
during the challenge session of the rapid-onset behavioral
sensitization test. The animals received a priming injection of vehicle (Veh-)
or 64 mg/kg modafinil (Mod64-) and, after 4 h, a challenge injection of vehicle
(-Veh) or 16 mg/kg (-Mod16), 32 mg/kg (-Mod32), or 64 mg/kg modafinil
(-Mod64). After 30 min, the locomotor activity was measured for 10 min in the
open field. Data are reported as mean ± SEM (n = 12).FP < 0.05 compared
with the Veh-Veh group. P < 0.05 compared with the respective control
group, which received a priming injection of vehicle. αP < 0.05 compared with
the Veh-Mod16 group. uP < 0.05 compared with all of the other groups.
of comparable basal locomotor activity: Veh (n = 10), Mod64
(n = 9), and Mod80 (n = 10). On the 4th day, animals received
an i.p. injection of vehicle solution (Veh), 64 mg/kg modafinil
(Mod64) or 80 mg/kg modafinil (Mod80). After 30 min, animals
were individually placed in the open field and the locomotor
activity was measured for 10 min.
Experiment 5. Rapid-Onset Behavioral
Cross-Sensitization to Cocaine after a Priming
Injection of Modafinil
Eighty-four mice were habituated to the open field (10-min
sessions) and to the injection procedure for three consecutive
days, and their locomotor activity was measured on day 3.
After the habituation phase, animals were allocated into seven
groups of comparable basal locomotor activity (n = 12): Veh-
Sal, Veh-Coc5, Mod64-Coc5, Veh-Coc10, Mod64-Coc10, Veh-
Coc20, and Mod64-Coc20. On the 4th day, animals received an
i.p. priming injection of vehicle solution (Veh-) or 64 mg/kg
modafinil (Mod64-). Immediately after the injections, animals
returned to their home cages. Four hours after their respective
priming injections, animals received an i.p. challenge injection
of saline solution (-Sal) or 5 mg/kg (-Coc5), 10 mg/kg (-Coc10),
or 20 mg/kg (-Coc20) cocaine. After 5 min, animals were
individually placed in the open field and the locomotor activity
was measured for 10 min.
Experiment 6. Rapid-Onset Behavioral
Cross-Sensitization to Modafinil after a Priming
Injection of Cocaine
Eighty-four mice were habituated to the open field (10-min
sessions) and to the injection procedure for three consecutive
days, and their locomotor activity was measured on day 3. After
the habituation phase, animals were allocated into seven groups
of comparable basal locomotor activity (n = 12): Sal-Veh, Sal-
Mod16, Coc20-Mod16, Sal-Mod32, Coc20-Mod32, Sal-Mod64,
and Coc20-Mod64. On the 4th day, animals received an i.p.
priming injection of saline solution (Sal-) or 20 mg/kg cocaine
(Coc20-). Immediately after the injections, animals returned to
their home cages. Four hours after their respective priming
injections, animals received an i.p. challenge injection of vehicle
solution (-Veh) or 16 mg/kg (-Mod16), 32 mg/kg (-Mod32),
or 64 mg/kg (-Mod64) modafinil. After 30 min, animals were
individually placed in the open field and the locomotor activity
was measured for 10 min.
The doses of cocaine for Experiments 5 and 6 were
chosen based on a previous study showing time-effect curves
of the locomotor stimulant effect induced by acute cocaine
administration in mice (Gatch et al., 2013).
RESULTS
Experiment 1. A Priming Injection of
Modafinil Induced Rapid-Onset
Behavioral Sensitization to a Challenge
Injection of Modafinil at Several Doses
Regarding the sensitization test (day 4), one-way ANOVA
revealed significant group differences [F(6,77) = 27.2, P < 0.05].
Tukey’s post hoc test revealed that with respect to animals acutely
treated with modafinil for the first time (priming injection of
vehicle and challenge injection of modafinil), only the Veh-
Mod32 and Veh-Mod64 groups presented a significant increase
in locomotion when compared with the Veh-Veh control
group, indicating that only the highest doses of modafinil were
effective in promoting locomotor stimulant effects. Furthermore,
the statistical analysis revealed that animals treated with a
priming injection of 64 mg/kg modafinil and challenged
with different doses of modafinil (Mod64-Mod16, Mod64-
Mod32, and Mod64-Mod64 groups) presented significantly
greater locomotor activity when compared to their respective
control groups treated initially with vehicle and challenged with
different doses of modafinil (Veh-Mod16, Veh-Mod32, and Veh-
Mod64 groups), characterizing the development of rapid-onset
behavioral sensitization to modafinil for all doses. In addition, the
magnitude of rapid-onset sensitization was greater for the highest
dose of modafinil during challenge session, as animals of the
Mod64-Mod64 group presented significantly greater locomotor
activity than animals of the Mod64-Mod16 and Mod64-Mod32
groups (Figure 1).
Experiments 2–4. Behavioral Effects and
Modafinil Plasma Concentrations 4 h
after 64 mg/kg Modafinil Acute
Administration
Figure 2 shows the locomotor activity of animals on the 3rd day
of habituation and during 240 min after acute administration
of 64 mg/kg modafinil. Two-way ANOVA revealed significant
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FIGURE 2 | Locomotor activity in the open field during the 3rd day of
habituation and throughout 270 min after acute administration of
vehicle (Veh) or 64 mg/kg modafinil (Mod64). During the open-field test,
locomotor activity was measured for 10 min, every 30 min, for a period of
240 min. Data are reported as mean ± SEM (n = 10).FP < 0.05 compared
with Veh group at the respective time interval.
FIGURE 3 | Locomotor activity in the open field during the 3rd day of
habituation and during the test session with vehicle or two different
doses of modafinil. The animals received an injection of vehicle solution
(Veh), 64 mg/kg (Mod64) or 80 mg/kg (Mod80) modafinil, and after 30 min,
the locomotor activity was measured for 10 min in the open field. Data are
reported as mean ± SEM. Veh (n = 10), Mod64 (n = 9), and Mod80 (n = 10).
FP < 0.05 compared with the Veh group.
effects of time (minutes of observation) [F(1,18) = 31.3,
P < 0.05], treatment (Sal × Mod64) [F(1,18) = 33.5, P < 0.05]
and a significant time × treatment interaction [F(1,18) = 22.0,
P< 0.05]. Tukey’s post hoc test revealed that animals that received
64 mg/kg modafinil had a significantly higher locomotor activity
compared to animals of the Veh group at 30, 60, 90, and 120 min
post-injection. After 120 min, animals of the Mod64 group
showed no significant differences in locomotor activity relative
to animals from the Veh group. These results show that after 4 h,
there was no longer a stimulating effect of modafinil on animals’
locomotion.
The plasma analysis showed that there was a significant
decrease in the concentration of modafinil in blood samples
taken 4 h after modafinil (17.3 ± 3.13 mg/ml) administration
(Mod4h group) compared to blood samples taken 30 min
(66.5 ± 3.03 mg/ml) after administration (Mod30min group)
[Student’s t-test: t(6)= 11.3, P < 0.0001].
With respect to Experiment 4, one-way ANOVA revealed
significant differences between groups on the test day (day 4)
[F(2,26 = 18.5, P < 0.05]. Tukey’s post hoc test revealed that
the animals treated acutely with 64 or 80 mg/kg modafinil
(Mod64 and Mod80 groups) presented a significant increase in
locomotion when compared to the Veh group, demonstrating
the locomotor stimulant effect of both doses of modafinil.
Importantly, the statistical analysis showed no significant
differences in locomotion of the animals treated with 64 mg/kg
modafinil compared to animals treated with 80 mg/kg modafinil
(Figure 3).
Experiment 5. A Priming Injection of
Modafinil Induced Rapid-Onset
Cross-Sensitization with a Challenge
Injection of Cocaine
Concerning the sensitization test (day 4), one-way ANOVA
revealed significant differences between groups [F(6,77) = 28.6,
P < 0.05]. Tukey’s post hoc test revealed that only the groups
treated acutely with high doses of cocaine (Veh-Coc10 and
Veh-Coc20) presented a significant increase in locomotion
when compared to the Veh-Sal group, which demonstrated the
locomotor stimulant effect of cocaine at these doses. Moreover,
the locomotor effects of a challenge injection of 20 mg/kg
cocaine were enhanced in mice pre-exposed to 64 mg/kg
modafinil (Mod64-Coc20), as compared to mice pre-exposed
to vehicle solution (Veh-Coc20), revealing a rapid-onset cross-
sensitization between modafinil and a high dose of cocaine.
Indeed, the locomotor activity presented by the Mod64-Coc20
group was significantly greater than all of the others groups
(Figure 4).
Experiment 6. A Priming Injection of
Cocaine Induced Rapid-Onset
Cross-Sensitization with a Challenge
Injection of Modafinil
During the sensitization test, significant differences between
groups were detected by one-way ANOVA [F(6,77) = 24.9,
P < 0.05]. Tukey’s post hoc test revealed that among the
groups previously treated with saline, only the Sal-Mod64
group, treated acutely with the highest dose of modafinil, had
increased locomotor activity when compared to the Sal-Veh
group, which demonstrated that only this dose was effective in
inducing a locomotor stimulant effect in mice. Importantly, the
locomotor effects of a challenge injection of 64 mg/kg modafinil
were enhanced in mice previously treated with 20 mg/kg
cocaine (Coc20-Mod64 group), as compared to mice previously
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FIGURE 4 | Locomotor activity during the 3rd day of habituation and
during the challenge session of the rapid-onset behavioral
sensitization test with saline or different doses of cocaine. The animals
received a priming injection of modafinil vehicle solution (Veh-) or 64 mg/kg
modafinil (Mod64-), and after 4 h, a challenge injection of saline (-Sal),
5 mg/kg (-Coc5), 10 mg/kg (Coc10), or 20 mg/kg (-Coc20) cocaine. After
5 min, the locomotor activity was measured for 10 min in the open field. Data
are reported as mean ± SEM (n = 12).FP < 0.05 compared with the
Veh-Sal group. P < 0.05 compared with the respective control group that
received a priming injection of vehicle solution. uP < 0.05 compared with all
of the other groups.
treated with saline (Sal-Mod64), revealing a rapid-onset cross-
sensitization between cocaine and a high dose of modafinil
(Figure 5).
DISCUSSION
The present study shows the following main findings: (1) a
priming injection of a high dose of modafinil (64 mg/kg) induced
rapid-onset sensitization to the locomotor stimulant effects of
low and high doses of modafinil administered 4 h later; and (2)
there was bidirectional rapid-onset cross-sensitization between
modafinil and cocaine, i.e., a modafinil priming injection induced
rapid-onset behavioral sensitization to a subsequent cocaine
challenge injection, and a cocaine priming injection induced
rapid-onset behavioral sensitization to a modafinil challenge
injection.
This is the first paper showing that behavioral sensitization
to modafinil can develop in such a rapid manner. As previously
mentioned, it has been demonstrated that a priming injection
of d-amphetamine at a high dose can elicit intense stereotyped
behaviors and high levels of locomotor activity in rats and
mice challenged with a sub-threshold dose of d-amphetamine a
few hours later (3–5 h) (Kuczenski and Segal, 1999a,b; Alvarez
et al., 2006; Chinen et al., 2006). The present study adds
to the literature by showing that modafinil was also able to
produce this rapid-onset type of behavioral sensitization in
mice. Behavioral sensitization induced by repeated treatment
with a drug in rodents has been extensively associated with
increased activity in the mesoaccumbens dopaminergic system
FIGURE 5 | Locomotor activity during the 3rd day of habituation and
during the challenge session of the rapid-onset behavioral
sensitization test with vehicle or different doses of modafinil. The
animals received a priming injection of saline (Sal-) or 20 mg/kg cocaine
(Coc20-), and after 4 h, a challenge injection of modafinil vehicle solution
(-Veh), 16 mg/kg (-Mod16), 32 mg/kg (-Mod32), or 64 mg/kg (-Mod64)
modafinil. After 30 min, the locomotor activity was measured for 10 min in the
open field. Data are reported as mean ± SEM (n = 12).FP < 0.05 compared
with the Sal-Veh group. P < 0.05 compared with the respective control
group that received a priming injection of saline. •P < 0.05 compared with the
Sal-Mod16 and Sal-Mod32 groups. uP < 0.05 compared with all of the other
groups.
(Robinson and Berridge, 2008). As for the rapid-onset behavioral
sensitization, the only data available regarding the underlying
mechanisms are those reported by Kuczenski and Segal
(1999b), which demonstrated that both dopamine D1 and D2
receptors are important for the induction and expression of
rapid-onset sensitization of stereotyped behaviors induced by
d-amphetamine in rats. Thus, the demonstration that modafinil
effectively produces rapid-onset locomotor sensitization provides
further support for the mesolimbic dopaminergic mechanism
of modafinil and suggests that a single dose of modafinil can
immediately lead to neuroplastic mechanisms thought to be
involved in drug abuse.
In fact, such neuroplastic changes can occur immediately
after the administration of a drug of abuse. In a recent study,
Muñoz-Cuevas et al. (2013) demonstrated in vivo the emergence
of new dendritic spines in the dorsomedial prefrontal cortex of
mice only 2 h after administration of cocaine that correlated
positively with cocaine-induced effects on animals’ behavior.
In addition, Kuczenski and Segal (1999a) demonstrated that
sub-threshold doses of both dopamine D1 and D2 receptors
agonists promoted stereotyped behaviors in rats primed with an
amphetamine injection a few hours before, suggesting that this
single injection of amphetamine enhanced sensitivity of both
D1 and D2 receptors in a very short time frame. The present
data, together with previous ones from our research group
(Wuo-Silva et al., 2011), reinforce the hypothesis that modafinil
alone has significant reinforcing effects that should not be
ruled out.
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Our results are contrary to the studies of Deroche-
Gamonet et al. (2002) and Shuman et al. (2012), which
suggest that modafinil would be devoid of abuse potential.
These studies showed that modafinil was not able to induce
conditioned place preference, self-administration, or behavioral
sensitization in rodents, indicating that modafinil would not
have reinforcing properties. However, there are important
methodological differences between those studies and ours that
could explain this discrepancy in results. In our study, mice
were placed in the open-field apparatus 30 min after modafinil
administration, where they remained for 10 min, while Deroche-
Gamonet et al. (2002) administered modafinil and immediately
placed the animals in the test apparatus. It is likely that because
of this lack of time between administration of modafinil and
the introduction of animals into the apparatus the behavioral
effects induced by modafinil were not observed at its peak effect.
With respect to the absence of modafinil-induced behavioral
sensitization in mice reported by Shuman et al. (2012), it is
worth noting that these authors evaluated the effects of modafinil
on the sensitization model following repeated administration
of the drug (classical sensitization protocol) and by challenging
the animals with a very low dose of modafinil (0.75 mg/kg).
In addition, sensitization was measured in the conditioned
place preference apparatus, which is most commonly used to
measure the reinforcing properties of drugs but not exactly the
best apparatus to measure the effects of drugs on locomotor
activity of rodents. Notwithstanding, Shuman et al. (2012) did
observe modafinil-induced conditioned place preference and an
interaction of modafinil and cocaine in the classical behavioral
sensitization model, similar to what we reported in our previous
study (Wuo-Silva et al., 2011) and what was reported in the study
from Nguyen et al. (2011).
One could argue that the behavioral results presented here
could be due to residual levels of the priming injection of
modafinil at the moment of the challenge session. However, this
possibility seems unlikely for several reasons. First, Experiment 2
demonstrated that 150 min after an acute injection of modafinil
at the same dose as the priming injection for Experiments 1
and 5 (64 mg/kg), the locomotor stimulating effect had ceased
completely. These results corroborate the findings of Duteil et al.
(1990), which showed that the locomotor stimulant effect of
64 mg/kg modafinil persisted for a period of 120 min in mice.
Second and supporting the behavioral data, blood sample analysis
(Experiment 3) indicated that modafinil plasma levels decreased
significantly 4 h after drug administration. Additionally, it is
worth mentioning that microdialysis studies in rats (Zolkowska
et al., 2009) and rhesus monkeys (Andersen et al., 2010) showed
that extracellular dopamine levels have a peak at 20 min after
administration of high doses of modafinil, returning to baseline
levels up to 100 min later. However, Loland et al. (2012) reported
that dopamine levels remained elevated in the nucleus accumbens
shell of mice for 6 h after modafinil administration. The results
presented by these authors are not compatible with the results
found in our study for the measurements of modafinil in plasma
of mice. Of note, Loland et al. (2012) used different doses of
modafinil (30, 100, and 300 mg/kg) than that used in our study
(64 mg/kg). This difference might have influenced the somewhat
discrepant findings between the studies. We should also point
out that the lack of measurement of brain levels of modafinil
is a limitation of our study. Studies have shown that cocaine
concentration in the brain appears to be more reliable than
plasma drug levels to predict behavioral changes in rodents
(Reith et al., 1987; Zombeck et al., 2009). However, there are
no studies showing a potential correlation between modafinil
levels in the brain and locomotor activity in rodents. Studies
have only assessed the levels of dopamine and its metabolites
in the brain following modafinil administration (see Andersen
et al., 2010; Mereu et al., 2016). Hereafter, further studies can
be performed in order to associate modafinil levels in the brain
and behavioral responses in mice, thereby providing important
insights into the mechanisms of the rapid-onset behavioral
sensitization phenomenon induced by modafinil.
Despite the significant reduction in modafinil plasma levels
described in Experiment 3, considerable levels of modafinil
in the plasma of animals were still detected 4 h after drug
administration. One could still speculate that this plasma residue
of modafinil might be able to interfere with the behavior of
animals and contribute to increase their locomotor activity
during the challenge session of the sensitization test. However,
this does not seem to be the case, as Experiment 4 demonstrated
that the animals receiving the dose of 80 mg/kg modafinil
(calculated residual dose combined with the challenge dose)
showed no significant difference in locomotor activity when
compared to mice receiving only the challenge dose of 64 mg/kg
modafinil. Another point raised here is that the lack of difference
in the locomotor stimulant effect induced by 64 mg/kg modafinil
compared to 80 mg/kg modafinil could be due to a ceiling effect.
This possibility seems unlikely, as we have previously shown that
the acute effect of a very high dose of modafinil (128 mg/kg)
was significantly greater than the locomotor-activating effect
of 64 mg/kg modafinil in the same mouse strain (Wuo-Silva
et al., 2011). In addition, Duteil et al. (1990) have shown similar
results, i.e., dose-dependent increases in locomotor activity of
mice induced by the doses of 32, 64, and 128 mg/kg modafinil.
Altogether, data from Experiments 2–4 support our
hypothesis that the enhanced locomotion observed in mice
receiving two modafinil injections at a 4-h interval demonstrates
the expression of a rapid-onset behavioral sensitization and is
not due to residual levels of the drug.
Supporting the idea that modafinil shares common plastic
neuronal mechanisms related to drug abuse, Experiments
5 and 6 demonstrated a bidirectional rapid-onset cross-
sensitization between modafinil and cocaine. In fact, there was
an enhancement of the locomotor stimulant effect of a challenge
injection of 20 mg/kg cocaine 4 h after administration of
64 mg/kg modafinil, as well as an enhancement of the locomotor
stimulant effect of a challenge injection of 64 mg/kg modafinil
4 h after administration of 20 mg/kg cocaine. These results are
in agreement with our previous study (Wuo-Silva et al., 2011)
showing that pre-treatment with repeated injections of cocaine
enhanced the locomotor stimulant effects of an acute injection
of modafinil, and pre-treatment with repeated injections of
modafinil enhanced the locomotor stimulant effects of an acute
injection of cocaine in mice. Similarly, Soeiro et al. (2012)
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demonstrated cross-sensitization between methamphetamine
and modafinil in mice. Altogether, the bidirectional cross-
sensitization between modafinil and other psychostimulants
seen in the present study and in previous ones suggests
that modafinil shares common neurobiological mechanisms
with psychostimulants related to both the induction and the
expression phases of sensitization. Within this context, while
events in the ventral tegmental area have been linked to the
induction of sensitization, events in the nucleus accumbens seem
to be responsible for the expression of this phenomenon (Pierce
and Kalivas, 1997).
Recent studies have shown that modafinil can also be
reinforcing to humans, as it can increase incentive salience (Smart
et al., 2013), motivation for reinforcement seeking (Young and
Geyer, 2010) and reward anticipation (Funayama et al., 2014).
Evidence suggests that the reinforcing effects of modafinil may
be related to the dopaminergic system, as seen for most of the
drugs with abuse potential. It has been shown that modafinil
increased dopamine levels in the nucleus accumbens shell and
core of mice (Mereu et al., 2016) at levels similar to those induced
by typical psychostimulants, and that this enhancement was due
to blockade of DAT (see Volkow et al., 2009; Andersen et al.,
2010; Kim et al., 2014). Zolkowska et al. (2009) demonstrated
that modafinil-induced increases in locomotor activity of rats are
mediated by this activity of modafinil on DAT and subsequent
increases on nucleus accumbens dopamine levels. Similarly,
Andersen et al. (2010) demonstrated that modafinil reinstated
cocaine-seeking behavior in rhesus monkeys by blocking DAT
and increasing extracellular dopamine concentrations in the
caudate-putamen.
Our results are also clinically relevant as they raise concerns
about the prescription of modafinil for drug abuse treatment
(Dackis et al., 2003, 2005, 2012; Hart et al., 2008). Hart et al.
(2008) and Vosburg et al. (2010) reported that modafinil reduced
measurements of subjective effects in cocaine addicts, such as
craving and reinforcement. However, it is important to emphasize
that even clinical studies that propose the use of modafinil for the
treatment of drug of abuse are contradictory. For example, Dackis
et al. (2005) demonstrated that modafinil decreased cocaine levels
in urine samples of cocaine addicts. In contrast, in a more
recent study, Dackis et al. (2012) showed that modafinil failed to
decrease the positive urine samples for cocaine in drug addicts.
Another concern regarding the clinical relevance of our study is
the increasing use of modafinil for non-medical purposes, such
as to increase cognitive ability (Cakic, 2009), to sustain alertness
in military pilots (Estrada et al., 2012) and even to improve
performance in athletes (Strano Rossi and Botrè, 2011). Of note,
recent studies have demonstrated that modafinil produces a
number of serious side effects, such as psychotic symptoms (Wu
et al., 2008) and severe cutaneous (Stevens-Johnson Syndrome)
and cardiovascular adverse reactions (Carstairs et al., 2010).
These studies, along with other data in the literature, led the
European Medicines Agency and the Agency’s Committee for
Medicinal Products for Human Use (2011) to restrict the use
of modafinil only for the treatment of narcolepsy. Given the
conflicting data regarding the effects of modafinil and its abuse
liability demonstrated in the present study, it could be expected
that, in the near future, modafinil might be classified as a drug of
abuse.
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